HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-islet-cell tumour hypoglycaemia (NICTH): About a series of 6 cases.

Abstract
The purpose of this study was to analyse the characteristics of 6 patients managed in a university hospital between 1996 and 2016 for non-islet cell tumor hypoglycemia (NICTH), a form of hypoglycaemia due to the paraneoplastic secretion of IGF-2 or its related substances. RESULTS: Three of these 6 patients (50%), aged over 69 years, including 2 with acromegaloid phenotype, presented with a pleural solitary fibrous tumor (SFT), with median diameter 20 cm (interquartile range, 12.5-20.5) with a low median SUV (3.3 g/mL (QR, 2-7.5)) on 18F-FDG PET. The other 3 patients presented respectively neuroendocrine carcinoma (NEC) of the palate (70-year-old woman), retroperitoneal myxofibrosarcoma (66-year-old man) and meningeal hemangiopericytoma (36-year-old woman). All 3 were inoperable and did not respond to any therapy other than glucose solution. Corticosteroid therapy was effective in the 3 SFTs and the NEC. One of the SFTs recurred 10 years later with asymptomatic hypoglycemia, which resolved after reintervention. Median (IQR) blood glucose levels of the 6 patients was 0.4g/L (QR, 0.31-0.41), with hypoinsulinemia at 0.7mIU/L (QR 0.7-2.0), undetectable GH, low IGF-1, normal IGF-2 level in 5/6 cases, a high IGF-2:IGF-1 ratio at 26.9 (QR, 20.8-37.8), hypokalemia and hypomagnesemia. CONCLUSION: NICTH is a rare syndrome, which should be considered in the presence of hypoinsulinemic hypoglycemia with low GH and IGF-1, and a IGF-2:IGF-1 ratio>10. Corticosteroid therapy was effective in elderly subjects, particularly with solitary fibrous tumor, which was generally operable. Hemangiopericytoma and myxofibrosarcoma had poor prognosis in younger patients.
AuthorsArnaud Jannin, Stéphanie Espiard, Kanza Benomar, Christine Do Cao, Bénédicte Mycinski, Henri Porte, Michèle D'Herbomez, Nicolas Penel, Marie-Christine Vantyghem
JournalAnnales d'endocrinologie (Ann Endocrinol (Paris)) Vol. 80 Issue 1 Pg. 21-25 (Feb 2019) ISSN: 2213-3941 [Electronic] France
PMID29555080 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2018 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Blood Glucose
  • IGF1 protein, human
  • IGF2 protein, human
  • Human Growth Hormone
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
  • Magnesium
  • Potassium
Topics
  • Adult
  • Aged
  • Blood Glucose (analysis)
  • Female
  • Fibroma
  • Fibrosarcoma (blood, complications)
  • Hemangiopericytoma (blood, complications)
  • Hospitals, University
  • Human Growth Hormone (blood)
  • Humans
  • Hypoglycemia (blood, drug therapy, etiology)
  • Insulin-Like Growth Factor I (analysis)
  • Insulin-Like Growth Factor II (analysis)
  • Magnesium (blood)
  • Male
  • Meningeal Neoplasms (blood, complications)
  • Neuroendocrine Tumors (blood, complications)
  • Potassium (blood)
  • Prognosis
  • Retroperitoneal Neoplasms (blood, complications)
  • Solitary Fibrous Tumor, Pleural (blood, complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: